Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Avoided shortage | 2022-02-02 | 2022-02-25 | 154043 |
| MYLAN-VARDENAFIL | 5MG | TABLET | Avoided shortage | 2021-12-21 | 2022-03-09 | 151666 |
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2022-02-23 | 2022-03-10 | 155442 |
| WIXELA INHUB | 50MCG 500MCG | POWDER | Resolved | 2022-03-11 | 2022-03-16 | 156586 |
| MYLAN-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2021-11-26 | 2022-03-23 | 149967 |
| MYLAN-ALMOTRIPTAN | 6.25MG | TABLET | Resolved | 2021-11-26 | 2022-03-23 | 149970 |
| MYLAN-LATANOPROST | 50MCG | SOLUTION | Resolved | 2022-03-15 | 2022-03-30 | 156728 |
| CLARUS | 40MG | CAPSULE | Resolved | 2022-01-13 | 2022-04-13 | 152648 |
| MYLAN-VARDENAFIL | 20MG | TABLET | Resolved | 2022-03-02 | 2022-04-27 | 155830 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Resolved | 2020-12-23 | 2022-05-11 | 130641 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-12-23 | 2022-05-11 | 130644 |
| MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Resolved | 2022-05-18 | 2022-05-25 | 160856 |
| MYLAN-ATAZANAVIR | 150MG | CAPSULE | Actual shortage | 2022-05-31 | 2022-05-31 | 161590 |
| MYLAN-ATAZANAVIR | 200MG | CAPSULE | Actual shortage | 2022-05-31 | 2022-05-31 | 161593 |
| MYLAN-ATAZANAVIR | 300MG | CAPSULE | Actual shortage | 2022-05-31 | 2022-05-31 | 161596 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Resolved | 2022-06-09 | 2022-06-15 | 162332 |
| MYLAN-ATOVAQUONE/PROGUANIL | 100MG 250MG | TABLET | Resolved | 2022-05-25 | 2022-06-22 | 161243 |
| MYLAN-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2022-05-18 | 2022-07-06 | 160866 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-01-13 | 2022-07-08 | 152651 |
| MYLAN-TADALAFIL | 20MG | TABLET | Resolved | 2022-01-13 | 2022-07-12 | 152654 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |